实用肿瘤学杂志
實用腫瘤學雜誌
실용종류학잡지
JOURNAL OF PRACTICAL ONCOLOGY
2014年
6期
503-507
,共5页
王晶%于航%王鹏%谢长英%倪秀芹
王晶%于航%王鵬%謝長英%倪秀芹
왕정%우항%왕붕%사장영%예수근
乳腺癌%雌激素%转移相关蛋白1%基质金属蛋白酶-9%金属蛋白酶组织抑制因子-1
乳腺癌%雌激素%轉移相關蛋白1%基質金屬蛋白酶-9%金屬蛋白酶組織抑製因子-1
유선암%자격소%전이상관단백1%기질금속단백매-9%금속단백매조직억제인자-1
Breast cancer%Estrogen%Metastasis-associated protein 1%Matrix metalloproteinase-9%Tis-sue inhibitor of metalloproteinases -1
目的:观察转移相关蛋白1( Metastasis associated protein 1,MTA1)在雌激素调控雌激素受体(Estrogen Recepto,ER)阳性乳腺癌细胞基质金属蛋白酶-9(Matrix metalloproteinase -9,MMP-9)、基质金属蛋白酶组织抑制因子( Tissue inhibitor of metalprotease -1,TIMP-1)中的可能作用。方法采用慢病毒转染MTA1-shRNA的方法建立特异性抑制MTA1表达的MCF-7模式细胞株。采用10 nM雌二醇(17β-estradiol,E2)处理细胞48 h,Real-time PCR、Western blot分别检测MMP-9、TIMP-1 mRNA与蛋白表达。结果 MTA1-shRNA最大抑制效率为84.9%,提示成功建立了抑制MTA1表达的MCF-7模式细胞株(MCF-7MTA1-shRNA)。 MCF-7野生株(MCF-7WT)在E2处理后MMP-9 mRNA和蛋白表达水平分别上升了46%(P<0.05)和37%(P<0.05),TIMP-1 mRNA和蛋白表达水平分别降低了32.3%(P<0.05)和18.2%(P<0.05);相对MCF-7WT,MCF-7MTA1-shRNA MMP-9 mRNA和蛋白表达水平分别降低了42.9%(P<0.05)和36.7%(P<0.05),TIMP-1 mRNA和蛋白表达水平未见显著变化;采用E2处理MCF-7MTA1-shRNA后,MMP-9 mRNA和蛋白表达水平未见明显变化,TIMP-1 mRNA和蛋白表达水平分别降低了25.4%(P<0.05)和32.2%(P<0.05)。结论 MTA1在雌激素上调ER阳性乳腺癌细胞MMP-9表达的信号转导通路中可能发挥重要作用,但未参与雌激素调控ER阳性乳腺癌细胞TIMP-1表达的信号转导通路。
目的:觀察轉移相關蛋白1( Metastasis associated protein 1,MTA1)在雌激素調控雌激素受體(Estrogen Recepto,ER)暘性乳腺癌細胞基質金屬蛋白酶-9(Matrix metalloproteinase -9,MMP-9)、基質金屬蛋白酶組織抑製因子( Tissue inhibitor of metalprotease -1,TIMP-1)中的可能作用。方法採用慢病毒轉染MTA1-shRNA的方法建立特異性抑製MTA1錶達的MCF-7模式細胞株。採用10 nM雌二醇(17β-estradiol,E2)處理細胞48 h,Real-time PCR、Western blot分彆檢測MMP-9、TIMP-1 mRNA與蛋白錶達。結果 MTA1-shRNA最大抑製效率為84.9%,提示成功建立瞭抑製MTA1錶達的MCF-7模式細胞株(MCF-7MTA1-shRNA)。 MCF-7野生株(MCF-7WT)在E2處理後MMP-9 mRNA和蛋白錶達水平分彆上升瞭46%(P<0.05)和37%(P<0.05),TIMP-1 mRNA和蛋白錶達水平分彆降低瞭32.3%(P<0.05)和18.2%(P<0.05);相對MCF-7WT,MCF-7MTA1-shRNA MMP-9 mRNA和蛋白錶達水平分彆降低瞭42.9%(P<0.05)和36.7%(P<0.05),TIMP-1 mRNA和蛋白錶達水平未見顯著變化;採用E2處理MCF-7MTA1-shRNA後,MMP-9 mRNA和蛋白錶達水平未見明顯變化,TIMP-1 mRNA和蛋白錶達水平分彆降低瞭25.4%(P<0.05)和32.2%(P<0.05)。結論 MTA1在雌激素上調ER暘性乳腺癌細胞MMP-9錶達的信號轉導通路中可能髮揮重要作用,但未參與雌激素調控ER暘性乳腺癌細胞TIMP-1錶達的信號轉導通路。
목적:관찰전이상관단백1( Metastasis associated protein 1,MTA1)재자격소조공자격소수체(Estrogen Recepto,ER)양성유선암세포기질금속단백매-9(Matrix metalloproteinase -9,MMP-9)、기질금속단백매조직억제인자( Tissue inhibitor of metalprotease -1,TIMP-1)중적가능작용。방법채용만병독전염MTA1-shRNA적방법건립특이성억제MTA1표체적MCF-7모식세포주。채용10 nM자이순(17β-estradiol,E2)처리세포48 h,Real-time PCR、Western blot분별검측MMP-9、TIMP-1 mRNA여단백표체。결과 MTA1-shRNA최대억제효솔위84.9%,제시성공건립료억제MTA1표체적MCF-7모식세포주(MCF-7MTA1-shRNA)。 MCF-7야생주(MCF-7WT)재E2처리후MMP-9 mRNA화단백표체수평분별상승료46%(P<0.05)화37%(P<0.05),TIMP-1 mRNA화단백표체수평분별강저료32.3%(P<0.05)화18.2%(P<0.05);상대MCF-7WT,MCF-7MTA1-shRNA MMP-9 mRNA화단백표체수평분별강저료42.9%(P<0.05)화36.7%(P<0.05),TIMP-1 mRNA화단백표체수평미견현저변화;채용E2처리MCF-7MTA1-shRNA후,MMP-9 mRNA화단백표체수평미견명현변화,TIMP-1 mRNA화단백표체수평분별강저료25.4%(P<0.05)화32.2%(P<0.05)。결론 MTA1재자격소상조ER양성유선암세포MMP-9표체적신호전도통로중가능발휘중요작용,단미삼여자격소조공ER양성유선암세포TIMP-1표체적신호전도통로。
Obej ctive To investigate the role of metastasis associated protein 1(MTA1)in estrogen reg-ulated expression of matrix metalloproteinase -9(MMP-9)and tissue inhibitor of metalprotease -1(TIMP-1) in estrogen receptor( ER ) positive breast cancer cells .Methods MTA1 knockdown cell model was generated based on MCF-7breast cancer cell line by transfected with MTA 1-shRNA.The mRNA and protein level of MMP-9 and TIMP-1 in wild type MCF-7(MCF-7WT)and MCF-7MTA1-shRNA before and after 17β-estradiol ( E2) treatment were examined by Real -time PCR and Western blot respectively .Results The MTA1-shRNA showed maximally 84.9%suppression of MTA1 expression in MCF-7,suggesting a satisfied MTA 1 knockdown cell model was established for subsequent experiments .After treated with E2 for 48 h,MCF-7WT showed an incre-ment of 46%(P<0.05)and 37%(P<0.05)of the mRNA and protein level of MMP -9 and a decrement of 32.3%( P<0.05)and 18.2%(P<0.05)of TIMP-1;MCF-7MTA1-shRNA showed a decrement of 32.3%(P<0.05)and 18.2%(P<0.05)of mRNA and protein expression of MMP -9 respectively but no significant differ-ence in TIMP-1 comparing with MCF-7WT before treated with Estradiol.After E2 treatment,MCF-7MTA1-shRNA didn′t show significant change of MMP -9 except decrements of 32.3%(P<0.05)and 18.2%(P<0.05)in the mRNA and protein levels of TIMP -1.Conclusion MTA1 may be involved in the pathway by which estrogen regulated the expression of MMP -9 but not TIMP-1 in ER positive breast cancer cells .